+ All Categories
Home > Documents > 1-Drug Affecting the Gastrointestinal System

1-Drug Affecting the Gastrointestinal System

Date post: 02-Jun-2018
Category:
Upload: crystal-arnold
View: 216 times
Download: 0 times
Share this document with a friend

of 27

Transcript
  • 8/10/2019 1-Drug Affecting the Gastrointestinal System

    1/27

    DRUG USED IN GASTRO

    INTESTINAL DISEASE

    DR.dr.Asep Sukohar, M.Kes

    Department of Pharmacology, Faculty Of Medicine,Lampung University

  • 8/10/2019 1-Drug Affecting the Gastrointestinal System

    2/27

    Many Drugs

    Have applications in the treatment ofgastro intestinal disease

    - motility

    - digestion

    - secretion

    - absorption

    - peptic ulcers

    - delayed gastric emptying in adequate propulsion- diarrhea

    - infections and inflammation

  • 8/10/2019 1-Drug Affecting the Gastrointestinal System

    3/27

    DRUG USED IN PEPTIC ULCERS

    DISEASE

    Pathogenesis of peptic ulcers not

    completely understood

    Secretion of acid by gastric parietal cells

    regulated by- Histamin

    - Asetylcholine

    - Gastrin

  • 8/10/2019 1-Drug Affecting the Gastrointestinal System

    4/27

    AGENT FOR CONTROL OF

    GASTRIC ACIDITY ANDTREATMENT OF PEPTIC ULCERS

    - Antacids

    - H2Receptor antagonists

    - Mucosal protective agents

    - Others agents

  • 8/10/2019 1-Drug Affecting the Gastrointestinal System

    5/27

    Antacids

    - Cimetidine

    - Ranitidine- Famatidine

    - Nizatidine

    - Alumunium hydroxide

    - Calcium carbonate

    - Magnesium hydroxide

    - Sodium bicarbonate

    - Magnesium trisilikate

    H2Histamin receptor-blockers

  • 8/10/2019 1-Drug Affecting the Gastrointestinal System

    6/27

    Mucosal protective agents

    - Sucralfate

    Studies in human subjects and with animal models of ulcer disease have shown that sucralfate forms an ulcer-adherent complex with proteinaceous exudateat the ulcer site.

    In vitro, a sucralfate-albumin film provides a barrier to diffusion of hydrogen ions.

    In human subjects, sucralfate given in doses recommended for ulcer therapy inhibits pepsin activity in gastricjuice

    by 32%.

    In vitro, sucralfate adsorbs bile salts.

    - Colloidal bismuth

    Inhibitors of proton pump

    - Omeprazol

    - Lansoprazol

    Prostaglandins- Misoprostal: inhibiting the secretion of gastric acidvia G-protein coupled receptor-mediated inhibition of adenylate cyclase,

    which leads to decreased intracellular cyclic AMPlevels and decreased proton pumpactivity at the apicalsurface of the

    parietal cell

    http://www.rxlist.com/script/main/art.asp?articlekey=9900http://www.rxlist.com/script/main/art.asp?articlekey=4033http://www.rxlist.com/script/main/art.asp?articlekey=3547http://en.wikipedia.org/wiki/Gastric_acidhttp://en.wikipedia.org/wiki/G-protein_coupled_receptorhttp://en.wikipedia.org/wiki/Adenylate_cyclasehttp://en.wikipedia.org/wiki/Cyclic_AMPhttp://en.wikipedia.org/wiki/Proton_pumphttp://en.wikipedia.org/wiki/Apical_membranehttp://en.wikipedia.org/wiki/Apical_membranehttp://en.wikipedia.org/wiki/Proton_pumphttp://en.wikipedia.org/wiki/Cyclic_AMPhttp://en.wikipedia.org/wiki/Adenylate_cyclasehttp://en.wikipedia.org/wiki/Adenylate_cyclasehttp://en.wikipedia.org/wiki/Adenylate_cyclasehttp://en.wikipedia.org/wiki/G-protein_coupled_receptorhttp://en.wikipedia.org/wiki/G-protein_coupled_receptorhttp://en.wikipedia.org/wiki/G-protein_coupled_receptorhttp://en.wikipedia.org/wiki/Gastric_acidhttp://www.rxlist.com/script/main/art.asp?articlekey=3547http://www.rxlist.com/script/main/art.asp?articlekey=4033http://www.rxlist.com/script/main/art.asp?articlekey=9900
  • 8/10/2019 1-Drug Affecting the Gastrointestinal System

    7/27

    Antimicrobial agents

    - Amoxicillin

    - Bismuth compounds

    - Claritromycin

    - Metronidazole

    - Tetracycline

  • 8/10/2019 1-Drug Affecting the Gastrointestinal System

    8/27

    Antacids

    Sodium BicarbonatNaHCO3 + HCl NaCl + H2O + CO2- Active ingredient in backing soda

    - Highly soluble

    absorbed rapidly from the gut

    promote systemic alkalosis and fluid retention

    Not recommended for long-term use

  • 8/10/2019 1-Drug Affecting the Gastrointestinal System

    9/27

  • 8/10/2019 1-Drug Affecting the Gastrointestinal System

    10/27

    Calcium Carbonate

    Ca Co3 + 2 Hcl CaCl2+ H2O + Co2

    - More slowly than sodium bicarbonate

    - Very effective in neutralyzing in gastric acid

    - 10% produced is absorbed

    potensial- hypercalcemia

    - milk alkali syndrome

    - acid rebound

    not recommended for long term use

  • 8/10/2019 1-Drug Affecting the Gastrointestinal System

    11/27

    Magnesium Hydroxide

    = Milk of Magnesia

    Mg(OH)2+ 2 HCl MgCl2 + 2 H2O

    - Prolonging its neutralizing effect

    - Magnesium salts

    cathartic effect- A small absorbed renal insufficiency

  • 8/10/2019 1-Drug Affecting the Gastrointestinal System

    12/27

    Magnesium Trisilikate

    Mg2Si308(nH2O) +4HT2 mg++ +

    3S1O2+(n+2)H2O

    - S1O2 - adsorbent- Siliceous nephroliths

  • 8/10/2019 1-Drug Affecting the Gastrointestinal System

    13/27

    H2HISTAMIN RECEPTOR

    ANTAGONITS

    Cimetidine }

    Ranitidine } 2 major drugs in use

    - Capable of over 90% reduction in based foodstimulated, and nocturnal secretion of gastricacid after a single dose

    - Promoting the healing of duodenal and gastriculcers and preventing their recurrence.

    Famotidine

    Nizatidine

  • 8/10/2019 1-Drug Affecting the Gastrointestinal System

    14/27

    Pharmacological Properties

    - H2Rec An. Competitively inhibit the interaction ofhistamine

    with H2 receptor

    - Highly selective

    - Absorption, Fate and Excretion

    - H2 Rec. An. . rapidly and well absorbed after oral

    ad.

    . peak C : 1 or 2 hours

    . bioavailability Niz : 91%

    . t : 2-3 hours

    1-3 hours : nizatidine

    . Exc : urine

  • 8/10/2019 1-Drug Affecting the Gastrointestinal System

    15/27

    - Adverse effects : - headache- dizziness and nausea

    - myalgia, skin rashes

    - itching

    - Drug interactions : - Antacid

    - Ketakenazole- cyt. P.450

  • 8/10/2019 1-Drug Affecting the Gastrointestinal System

    16/27

  • 8/10/2019 1-Drug Affecting the Gastrointestinal System

    17/27

    Inbitors of H+, K+ATP ase

    Omeprazole

    Lansoprazole

    - Inhibition of gastric acid secretion

    - Do not affect gastric motility

    - Absorption : rapidly

    - Bioavailability : 70%

    - 95% bound to plasma protein

    - t : 30-40

    - Metabolism : hepatic- Exc : urine

    - Adverse effects - gastrointestinal

    - C.N.S

  • 8/10/2019 1-Drug Affecting the Gastrointestinal System

    18/27

    PROSTAGLANDIN ANALOGS

  • 8/10/2019 1-Drug Affecting the Gastrointestinal System

    19/27

    PROSTAGLANDIN ANALOGS

    PG E2}

    }

    PGI2 }

    - Predominant PG synthesized the gastric mucosa

    - Inhibit the secretion acid

    - Stimulate the secretion of mucus and

    - bicarbonat

    Misoprostol

    - 1.5 deoxy 16 hydroxy 16-metyl PGE1- Available in the U.S

    - Effective in treating - duodenal and

    - gastric ulcers

    inhibits gastric acid secretion

    produce cyproprotective effects

  • 8/10/2019 1-Drug Affecting the Gastrointestinal System

    20/27

    Pancreatic Enzime

    Replacement Product

    Two mayor types of preparation in use

    - Pancreatin } amylase

    } trypsim-Pancrelipase } lipase

    - Pepsime

    - Pancreatime

    - Dyastase

    - Dehidrocyolate acid

  • 8/10/2019 1-Drug Affecting the Gastrointestinal System

    21/27

    Irritant or stimulant laxatives

    - Castor oil

    - Cascara }

    - Senna } Difenilmetane

    - Aloes }

    - Phenolphtalien }

    } Anthrakinon

    - Bisacodyl }

    peristalsis is stimulated

    Laxatives

  • 8/10/2019 1-Drug Affecting the Gastrointestinal System

    22/27

    Drugs promoting

  • 8/10/2019 1-Drug Affecting the Gastrointestinal System

    23/27

    Drugs promoting

    Gastrointestinal motility

    * Bethanecol cholinergic agonist

    * Metoclopramide

    - Facilitating small bowel inhibition

    - Gastric motor failure

    - Particularly diabetic gastroporesis

    - After vagotomy- Disorders of gastric emptying

    - Gastroesophageal reflux disease

    - cancer chemotherapy

    - Rapidly absorbed- Peak C : 40 120

    - t : 4 hours

    - Excretion : kidneys

    - 10 mg 4 times daily - neal

    - bed time

  • 8/10/2019 1-Drug Affecting the Gastrointestinal System

    24/27

    Most widelly used prescription drugs1. Diphenoxylate (with atropine)

    analog of meperidine

    2. Loperamide

    haloperidol

    mechanisme of action : similar to that of the opioids

    Kaolin } adsorbents

    Pectin }

    also widely used

    Antidiarrheal Drugs

  • 8/10/2019 1-Drug Affecting the Gastrointestinal System

    25/27

    Drugs Used in The Treatment of Bowel Chranic

    Inflammatory Bowel disease

    ulcerative collitis

    chrohms disease

    - Corticosteroids

    - Other immunosuppressive agents

    Sulfasalazine

    combines sulfapyridine

    - 5 aminosalicylic acid

    poorly absorbed from the intestine

    MOA unknown

    cytoprotective role ?

    3-4g daily individed doses

    Azodisalicylate

  • 8/10/2019 1-Drug Affecting the Gastrointestinal System

    26/27

    How to formulate drugs?GG 979

  • 8/10/2019 1-Drug Affecting the Gastrointestinal System

    27/27

    Clinical Summary GG 980


Recommended